282 related articles for article (PubMed ID: 25457261)
1. Limited efficacy of topical recombinant feline interferon-omega for treatment of cats with acute upper respiratory viral disease.
Ballin AC; Schulz B; Helps C; Sauter-Louis C; Mueller RS; Hartmann K
Vet J; 2014 Dec; 202(3):466-70. PubMed ID: 25457261
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of passively transferred antibodies in cats with acute viral upper respiratory tract infection.
Friedl Y; Schulz B; Knebl A; Helps C; Truyen U; Hartmann K
Vet J; 2014 Sep; 201(3):316-21. PubMed ID: 24929533
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical ocular administration of high doses of human recombinant interferon alpha-2b and feline recombinant interferon omega on naturally occurring viral keratoconjunctivitis in cats.
Slack JM; Stiles J; Leutenegger CM; Moore GE; Pogranichniy RM
Am J Vet Res; 2013 Feb; 74(2):281-9. PubMed ID: 23363355
[TBL] [Abstract][Full Text] [Related]
4. Sampling sites for detection of feline herpesvirus-1, feline calicivirus and Chlamydia felis in cats with feline upper respiratory tract disease.
Schulz C; Hartmann K; Mueller RS; Helps C; Schulz BS
J Feline Med Surg; 2015 Dec; 17(12):1012-9. PubMed ID: 25660223
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats.
Matsumoto H; Teshima T; Iizuka Y; Sakusabe A; Takahashi D; Amimoto A; Koyama H
Res Vet Sci; 2018 Dec; 121():53-58. PubMed ID: 30359811
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
[TBL] [Abstract][Full Text] [Related]
7. Detection of feline upper respiratory tract disease pathogens using a commercially available real-time PCR test.
Litster A; Wu CC; Leutenegger CM
Vet J; 2015 Nov; 206(2):149-53. PubMed ID: 26324635
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of acute viral feline upper respiratory tract infections].
Bergmann M; Ballin A; Schulz B; Dörfelt R; Hartmann K
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2019 Apr; 47(2):98-109. PubMed ID: 31013527
[TBL] [Abstract][Full Text] [Related]
9. Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease.
Kopecny L; Maggs DJ; Leutenegger CM; Johnson LR
J Feline Med Surg; 2020 Jun; 22(6):492-499. PubMed ID: 31246133
[TBL] [Abstract][Full Text] [Related]
10. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus.
Binns SH; Dawson S; Speakman AJ; Cuevas LE; Hart CA; Gaskell CJ; Morgan KL; Gaskell RM
J Feline Med Surg; 2000 Sep; 2(3):123-33. PubMed ID: 11716607
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of intranasal vaccine administration and high-dose interferon- α2b therapy for treatment of chronic upper respiratory tract infections in shelter cats.
Fenimore A; Carter K; Fankhauser J; Hawley JR; Lappin MR
J Feline Med Surg; 2016 Aug; 18(8):603-11. PubMed ID: 26269455
[TBL] [Abstract][Full Text] [Related]
12. Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland.
Berger A; Willi B; Meli ML; Boretti FS; Hartnack S; Dreyfus A; Lutz H; Hofmann-Lehmann R
BMC Vet Res; 2015 Nov; 11():282. PubMed ID: 26566897
[TBL] [Abstract][Full Text] [Related]
13. Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells.
Bracklein T; Theise S; Metzler A; Spiess BM; Richter M
Am J Vet Res; 2006 Jun; 67(6):1025-32. PubMed ID: 16740097
[TBL] [Abstract][Full Text] [Related]
14. Clinical and antiviral effect of a single oral dose of famciclovir administered to cats at intake to a shelter.
Litster AL; Lohr BR; Bukowy RA; Thomasy SM; Maggs DJ
Vet J; 2015 Feb; 203(2):199-204. PubMed ID: 25542064
[TBL] [Abstract][Full Text] [Related]
15. Isolation of feline herpesvirus-1 and feline calicivirus from healthy cats in Swedish breeding catteries.
Holst BS; Berndtsson LT; Englund L
J Feline Med Surg; 2005 Dec; 7(6):325-31. PubMed ID: 15914057
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophages are the main target cells in feline calicivirus-associated pneumonia.
Monné Rodriguez JM; Soare T; Malbon A; Blundell R; Papoula-Pereira R; Leeming G; Köhler K; Kipar A
Vet J; 2014 Aug; 201(2):156-65. PubMed ID: 24857252
[TBL] [Abstract][Full Text] [Related]
17. Oral Recombinant Feline Interferon-Omega as an alternative immune modulation therapy in FIV positive cats: clinical and laboratory evaluation.
Gil S; Leal RO; McGahie D; Sepúlveda N; Duarte A; Niza MM; Tavares L
Res Vet Sci; 2014 Feb; 96(1):79-85. PubMed ID: 24332273
[TBL] [Abstract][Full Text] [Related]
18. Antiviral effect of mefloquine on feline calicivirus in vitro.
McDonagh P; Sheehy PA; Fawcett A; Norris JM
Vet Microbiol; 2015 Apr; 176(3-4):370-7. PubMed ID: 25746684
[TBL] [Abstract][Full Text] [Related]
19. Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter.
Zicola A; Saegerman C; Quatpers D; Viandier J; Thiry E
J Feline Med Surg; 2009 Dec; 11(12):1023-7. PubMed ID: 19577497
[TBL] [Abstract][Full Text] [Related]
20. Cat flu: Broad spectrum polymeric antivirals.
Synowiec A; Gryniuk I; Pachota M; Strzelec Ł; Roman O; Kłysik-Trzciańska K; Zając M; Drebot I; Gula K; Andruchowicz A; Rajfur Z; Szczubiałka K; Nowakowska M; Pyrc K
Antiviral Res; 2019 Oct; 170():104563. PubMed ID: 31325462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]